Regeneron Pharmaceuticals

Contact
regeneron.com
+1914-345-7400

Regeneron Pharmaceuticals Inc.

777 Old Saw Mill River Road
10591 Tarrytown
USA
+1914-345-7400
regeneron.com
Contact
Profile Products News
Contact

About Regeneron Pharmaceuticals

Get in the Ideas Business. At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work together to discover, invent, and develop biopharmaceutical medicines, we're creating whole new ways of thinking about science, manufacturing and commercialization. And whole new ways of thinking about health.

Read more about Regeneron Pharmaceuticals
Facts about Regeneron Pharmaceuticals
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Regeneron Pharmaceuticals

Product portfolio

Show all

News about Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

29-Jul-2021 | business & finance

AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity

Novel small molecule drug candidates will target GPR75 to potentially address obesity and related co-morbidities

Read news
Regeneron Pharmaceuticals

29-Jul-2015 | business & finance

Sanofi and Regeneron Launch Major New Immuno-Oncology Collaboration

Companies agree to jointly advance PD-1 and other new immuno-oncology antibodies

Read news
Regeneron Pharmaceuticals

21-Nov-2014 | research and development

Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

Sanofi and Regeneron Pharmaceuticals, Inc. announced new detailed positive results from six Phase 3 ODYSSEY trials that showed alirocumab significantly ...

Read news
Regeneron Pharmaceuticals

13-Nov-2009 | business & finance

Sanofi-aventis and Regeneron expand strategic Antibody Collaboration

Collaboration goal is to advance 4 to 5 antibodies per year into clinical development

Read news
Regeneron Pharmaceuticals

02-Oct-2007 | research and development

Bayer HealthCare: positive phase 2 results for the VEGF Trap-Eye

Bayer HealthCare and development partner Regeneron Pharmaceuticals, Inc. announced positive results from a Phase 2 study evaluating the VEGF Trap-Eye in ...

Read news
Regeneron Pharmaceuticals

29-Mar-2007 | research and development

Phase-II-Studie für VEGF Trap-Eye zeigt positive Zwischenergebnisse bei altersbedingter Makula-Degeneration

Bayer HealthCare und Regeneron planen Start einer Phase-III-Studie im zweiten Halbjahr 2007

Read news
Regeneron Pharmaceuticals

16-Apr-2004 | business & finance

Regeneron And Aventis Begin Study Of Intravenous VEGF Trap In Cancer

Tarrytown, New York - Regeneron Pharmaceuticals, Inc. announced the initiation of a Phase I Clinical Trial in cancer to assess the safety and tolerability ...

Read news
Regeneron Pharmaceuticals

05-Apr-2004 | business & finance

Regeneron To Receive 42.75 Million From Novartis To Satisfy Novartis' Remaining Funding Obligation For Development Of The IL-1 T

Regeneron Also Achieves Development Milestone, Resulting In Loan Forgiveness

Read news
Show more news about Regeneron Pharmaceuticals

Here you will find Regeneron Pharmaceuticals Inc.